LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
3,302,137
Share change
+1,848,975
Total reported value
$30,310,000
Price per share
$9.18
Number of holders
21
Value change
+$16,513,855
Number of buys
12
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q2 2014

As of 30 Jun 2014, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,302,137 shares. The largest 10 holders included FRANKLIN RESOURCES INC, TANG CAPITAL MANAGEMENT LLC, FMR LLC, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, Belmont Global Advisors, Inc., Iguana Healthcare Management, LLC, Trellus Management Company, LLC, SSI INVESTMENT MANAGEMENT INC, and TOCQUEVILLE ASSET MANAGEMENT L.P.. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.